RecruitingNCT06326892

Natural Orifice Specimen Extraction in Low Rectal Cancer Surgery

Postoperative Outcomes of Natural Orifice Specimen Extraction (NOSE) in Low Rectal Cancer Surgery


Sponsor

Istituto Clinico Humanitas

Enrollment

350 participants

Start Date

Jul 31, 2023

Study Type

OBSERVATIONAL

Conditions

Summary

This study aims to compare the postoperative outcomes of low rectal cancer patients who underwent surgery with Natural Orifice Specimen Extraction (NOSE) versus traditional Pfannenstiel extraction.


Eligibility

Min Age: 18 Years

Inclusion Criteria2

  • Patients undergoing low anterior resection with Total Mesorectal Excision (TME) for low rectal cancer between January 2017 and January 2023
  • Patients with rectal cancer classified as "low" according to the English National Low Rectal Cancer Development Programme (LOREC)

Exclusion Criteria4

  • Patients undergoing non-restorative procedures
  • Patients undergoing immediate or delayed handsewn coloanal anastomosis
  • Patients undergoing planned open surgery or unplanned conversion from minimally invasive to open surgery
  • Patients with a concomitant diagnosis of Inflammatory Bowel Disease (IBD)

Interventions

PROCEDURENatural Orifice Specimen Extraction (NOSE)

Low rectal cancer resection with Total Mesorectal Excision (TME) and Natural Orifice Specimen Extraction (NOSE)

PROCEDURETraditional specimen extraction

Low rectal cancer resection with Total Mesorectal Excision (TME) and specimen extraction through Pfannenstiel incision


Locations(1)

IRCCS Humanitas Research Hospital

Rozzano, MI, Italy

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06326892


Related Trials